Stay updated on Ociperlimab Plus Tislelizumab vs Durvalumab in cCRT Clinical Trial

Sign up to get notified when there's something new on the Ociperlimab Plus Tislelizumab vs Durvalumab in cCRT Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Ociperlimab Plus Tislelizumab vs Durvalumab in cCRT Clinical Trial page

  1. Check
    yesterday
    No Change Detected
  2. Check
    8 days ago
    Change Detected
    Summary
    Version 8 (2024-10-09) adds new sections such as Document Section, Participant Flow, Baseline Characteristics, Outcome Measures (Results), Adverse Events, and Limitations and Caveats, and updates multiple areas including Study Identification, Study Status, Study Description, Arms and Interventions, and Contacts/Locations.
    Difference
    0.1%
    Check dated 2025-11-03T21:08:23.000Z thumbnail image
  3. Check
    15 days ago
    No Change Detected
  4. Check
    37 days ago
    Change Detected
    Summary
    - Added a government operating-status notice and links, clarifying NIH Clinical Center operations and where to check updates. - Updated version from v3.1.0 to v3.2.0.
    Difference
    11%
    Check dated 2025-10-06T05:48:07.000Z thumbnail image
  5. Check
    44 days ago
    Change Detected
    Summary
    - Updated version from v3.0.2 to v3.1.0. - No other content changes detected.
    Difference
    0.3%
    Check dated 2025-09-29T03:09:46.000Z thumbnail image
  6. Check
    58 days ago
    Change Detected
    Summary
    Page revision updated from v3.0.1 to v3.0.2, and the 'Back to Top' element was removed.
    Difference
    0.7%
    Check dated 2025-09-14T19:27:54.000Z thumbnail image
  7. Check
    65 days ago
    Change Detected
    Summary
    The web page has been updated from version 3.0.0 to version 3.0.1, indicating a revision in the content.
    Difference
    0.7%
    Check dated 2025-09-07T16:44:44.000Z thumbnail image
  8. Check
    72 days ago
    Change Detected
    Summary
    The web page has undergone significant updates, including the addition of a facility name and location details, while removing specific state, country, and city information.
    Difference
    19%
    Check dated 2025-08-31T12:04:47.000Z thumbnail image

Stay in the know with updates to Ociperlimab Plus Tislelizumab vs Durvalumab in cCRT Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Ociperlimab Plus Tislelizumab vs Durvalumab in cCRT Clinical Trial page.